| Ident. | Authors (with country if any) | Title |
|---|
| 000013 (2020) |
Cem Gabay [Suisse] ; Gerd R. Burmester [Allemagne] ; Vibeke Strand [États-Unis] ; Jérôme Msihid [France] ; Moshe Zilberstein [États-Unis] ; Toshio Kimura [États-Unis] ; Hubert Van Hoogstraten [États-Unis] ; Susan H. Boklage [États-Unis] ; Jonathan Sadeh [États-Unis] ; Neil M. H. Graham [États-Unis] ; Anita Boyapati [États-Unis] | Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes |
| 000033 (2020) |
Jacqueline M. Tarrant [États-Unis] ; René Galien [France] ; Wanying Li [États-Unis] ; Lovely Goyal [États-Unis] ; Yang Pan [États-Unis] ; Rachael Hawtin [États-Unis] ; Wangshu Zhang [États-Unis] ; Annegret Van Der Aa [Belgique] ; Peter C. Taylor [Royaume-Uni] | Filgotinib, a JAK1 Inhibitor, Modulates Disease-Related Biomarkers in Rheumatoid Arthritis: Results from Two Randomized, Controlled Phase 2b Trials |
| 000096 (2019) |
Mélanie Rinaudo-Gaujous ; Vincent Blasco-Baque ; Pierre Miossec ; Philippe Gaudin ; Pierre Farge ; Xavier Roblin ; Thierry Thomas [France] ; Stephane Paul ; Hubert Marotte [France] | Infliximab Induced a Dissociated Response of Severe Periodontal Biomarkers in Rheumatoid Arthritis Patients |
| 000100 (2019) |
Mohit Sachdeva ; Philippe Duchateau [France] ; Stéphane Depil [France] ; Laurent Poirot [France] ; Julien Valton | Granulocyte–macrophage colony-stimulating factor inactivation in CAR T-cells prevents monocyte-dependent release of key cytokine release syndrome mediators |
| 000113 (2019) |
Alexandre Virone [France] ; Jean-Philippe Bastard [France] ; Soraya Fellahi [France] ; Jacqueline Capeau [France] ; Stéphanie Rouanet [France] ; Jean Sibilia [France] ; Philippe Ravaud [France] ; Francis Berenbaum [France] ; Jacques-Eric Gottenberg [France] ; Jérémie Sellam [France] | Comparative effect of tumour necrosis factor inhibitors versus other biological agents on cardiovascular risk-associated biomarkers in patients with rheumatoid arthritis |
| 000176 (2018) |
Eugen Feist [Allemagne] ; Stéphane Mitrovic [France] ; Bruno Fautrel [France] | Mechanisms, biomarkers and targets for adult-onset Still’s disease |
| 000236 (2017) |
Ingeborg M. Bajema [Pays-Bas] ; Jan A. Bruijn [Pays-Bas] ; Alina Casian [Royaume-Uni] ; Maria C. Cid [Espagne] ; Elena Csernok [Allemagne] ; Emma Van Daalen [Pays-Bas] ; Lorraine Harper [Royaume-Uni] ; Thomas Hauser [Suisse] ; Mark A. Little [Irlande (pays)] ; Raashid A. Luqmani [Royaume-Uni] ; Alfred Mahr [France] ; Cristina Ponte [Portugal] ; Alan Salama [Royaume-Uni] ; M Rten Segelmark [Suède] ; Kazuo Suzuki [Japon] ; Jan Sznajd [Royaume-Uni] ; Y. K. Onno Teng [Pays-Bas] ; Augusto Vaglio [Italie] ; Kerstin Westman [Suède] ; David Jayne [Royaume-Uni] | The European Vasculitis Society 2016 Meeting Report |
| 000237 (2017) |
Sarah Salomon [France] ; Caroline Guignant [France] ; Pierre Morel [France] ; Gauthier Flahaut [France] ; Clément Brault [France] ; Clément Gourguechon [France] ; Patrice Fardellone [France] ; Jean-Pierre Marolleau [France] ; Brigitte Gubler [France] ; Vincent Goëb [France] | Th17 and CD24hiCD27+ regulatory B lymphocytes are biomarkers of response to biologics in rheumatoid arthritis |
| 000252 (2017) |
C. Derambure [France] ; G. Dzangue-Tchoupou [France] ; C. Berard [France] ; N. Vergne [France] ; M. Hiron [France] ; M. A. D Gostino [France] ; P. Musette [France] ; O. Vittecoq [France] ; T. Lequerré [France] | Pre-silencing of genes involved in the electron transport chain (ETC) pathway is associated with responsiveness to abatacept in rheumatoid arthritis |
| 000259 (2017) |
Lasse Folkersen [Danemark, Suède] ; Eric Fauman [États-Unis] ; Maria Sabater-Lleal [Suède] ; Rona J. Strawbridge [Suède] ; Mattias Fr Nberg [Suède] ; Bengt Sennblad [Suède] ; Damiano Baldassarre [Italie] ; Fabrizio Veglia [Italie] ; Steve E. Humphries [Royaume-Uni] ; Rainer Rauramaa [Finlande] ; Ulf De Faire [Suède] ; Andries J. Smit [Pays-Bas] ; Philippe Giral [France] ; Sudhir Kurl [Finlande] ; Elmo Mannarino [Italie] ; Stefan Enroth [Suède] ; Sa Johansson [Suède] ; Sofia Bosdotter Enroth [Suède] ; Stefan Gustafsson [Suède] ; Lars Lind [Suède] ; Cecilia Lindgren [Royaume-Uni] ; Andrew P. Morris [Royaume-Uni] ; Vilmantas Giedraitis [Royaume-Uni] ; Angela Silveira [Suède] ; Anders Franco-Cereceda [Suède] ; Elena Tremoli [Italie] ; Ulf Gyllensten [Suède] ; Erik Ingelsson [Suède, États-Unis] ; S Ren Brunak [Danemark] ; Per Eriksson [Suède] ; Daniel Ziemek [États-Unis] ; Anders Hamsten [Suède] ; Anders M Larstig [Suède] | Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease |
| 000298 (2016) |
A. Deroux [France] ; F. Andry [France] ; L. Bouillet [France] | [Macrophage activation syndrome secondary to tocilizumab: Myth or reality?]. |
| 000313 (2016) |
Anita Boyapati [États-Unis] ; Jérôme Msihid [France] ; Stefano Fiore [États-Unis] ; Janet Van Adelsberg [États-Unis] ; Neil M. H. Graham [États-Unis] ; Jennifer D. Hamilton [États-Unis] | Sarilumab plus methotrexate suppresses circulating biomarkers of bone resorption and synovial damage in patients with rheumatoid arthritis and inadequate response to methotrexate: a biomarker study of MOBILITY |
| 000396 (2015) |
Paolo A. Ascierto [Italie] ; Michael Atkins [États-Unis] ; Carlo Bifulco [États-Unis] ; Gerardo Botti [Italie] ; Alistair Cochran [États-Unis] ; Michael Davies [États-Unis] ; Sandra Demaria [États-Unis] ; Reinhard Dummer [Suisse] ; Soldano Ferrone [États-Unis] ; Silvia Formenti [États-Unis] ; Thomas F. Gajewski [États-Unis] ; Claus Garbe [Allemagne] ; Samir Khleif [États-Unis] ; Rolf Kiessling [Suède] ; Roger Lo [États-Unis] ; Paul Lorigan [Royaume-Uni] ; Grant Mc Arthur [Australie] ; Giuseppe Masucci [Suède] ; Ignacio Melero ; Martin Mihm [États-Unis] ; Giuseppe Palmieri [Italie] ; Giorgio Parmiani [Italie] ; Igor Puzanov [États-Unis] ; Pedro Romero [Suisse] ; Bastian Schilling [Allemagne] ; Barbara Seliger [Allemagne] ; David Stroncek [États-Unis] ; Janis Taube [États-Unis] ; Sara Tomei [Qatar] ; Hassane M. Zarour [États-Unis] ; Alessandro Testori [Italie] ; Ena Wang [Qatar] ; Jérôme Galon [France] ; Gennaro Ciliberto [Italie] ; Nicola Mozzillo [Italie] ; Francesco M. Marincola [Qatar] ; Magdalena Thurin [États-Unis] | Future perspectives in melanoma research: meeting report from the “Melanoma Bridge”: Napoli, December 3rd–6th 2014 |
| 000400 (2015) |
V. Boom [Pays-Bas] ; J. Anton [Espagne] ; P. Lahdenne [Finlande] ; P. Quartier [France] ; A. Ravelli [Italie] ; N. M. Wulffraat [Pays-Bas] ; S. J. Vastert [Pays-Bas] | Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis |
| 000455 (2014) |
Anne C. Bay-Jensen [Danemark] ; Adam Platt [Royaume-Uni] ; Inger Byrjalsen [Danemark] ; Philippe Vergnoud [France] ; Claus Christiansen [Danemark] ; Morten A. Karsdal [Danemark] | Effect of tocilizumab combined with methotrexate on circulating biomarkers of synovium, cartilage, and bone in the LITHE study. |
| 000459 (2014) |
Delphine Dénarié [France] ; Elodie Constant [France] ; Thierry Thomas [France] ; Hubert Marotte [France] | Could Biomarkers of Bone, Cartilage or Synovium Turnover Be Used for Relapse Prediction in Rheumatoid Arthritis Patients? |
| 000638 (2012) |
Gilles Paintaud [France] ; Marine Diviné [France] ; Philippe Lechat [France] | Monoclonal Antibodies for Therapeutic Use: Specific Characteristics of Clinical Development, Evaluation by the Agencies, and Long-term Monitoring of Safety |
| 000677 (2011) |
Sylvie Fabre [France] | Approches pharmacologiques en immuno-rhumatologie |
| 000706 (2010) |
Jun Hashimoto [Japon] ; Patrick Garnero [France] ; Désirée Van Der Heijde [Pays-Bas] ; Nobuyuki Miyasaka [Japon] ; Kazuhiko Yamamoto [Japon] ; Shinichi Kawai [Japon] ; Tsutomu Takeuchi [Japon] ; Hideki Yoshikawa [Japon] ; Norihiro Nishimoto [Japon] | Humanized anti-interleukin-6-receptor antibody (tocilizumab) monotherapy is more effective in slowing radiographic progression in patients with rheumatoid arthritis at high baseline risk for structural damage evaluated with levels of biomarkers, radiography, and BMI: data from the SAMURAI study |
